Overexpression of Sirt6 promotes M2 macrophage transformation, alleviating renal injury in diabetic nephropathy

Ji,Liqiang; Chen,Yifang; Wang,Hongqiang; Zhang,Wei; He,Lanxiang; Wu,Jingmin; Liu,Yinghui

doi:10.3892/ijo.2019.4800

Overexpression of Sirt6 promotes M2 macrophage transformation, alleviating renal injury in diabetic nephropathy

Authors:
- Liqiang Ji
- Yifang Chen
- Hongqiang Wang
- Wei Zhang
- Lanxiang He
- Jingmin Wu
- Yinghui Liu
View Affiliations

Affiliations: Department of Pharmacy, The First People's Hospital of Yuhang District, Hangzhou, Zhejiang 311100, P.R China, Department of Pharmacy, Hangzhou Yuhang TCM Hospital, Hangzhou, Zhejiang 311106, P.R China, Department of Endocrinology, Zhejiang Provincial Integrated Chinese and Western Medicine Hospital, Hangzhou Red Cross Hospital, Hangzhou, Zhejiang 310003, P.R China
Published online on: May 14, 2019 https://doi.org/10.3892/ijo.2019.4800
Pages: 103-115
Copyright: © Ji et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

In this study, we aimed to investigate the associations between Sirt6, macrophages and diabetic nephropathy (DN). Immunohistochemical, western blot and RT‑qPCR analyses were performed to detect the expression levels of Sirt6, the markers of podocytes and monocytes and related inflammatory factors in the tissues of rats with streptozocin‑induced DN. A series of cell experiments in isolated culture or the co‑culture of macrophages and podocytes were conducted to examine the effects of the overexpression of Sirt6 on macrophage transformation, podocyte apoptosis and associated genes, and analyses were performed using RT‑qPCR, flow cytometry and western blot analysis, where appropriate. In the rat model of DN, injured podocytes were represented by the decreased protein expression levels of Nephrin and Sirt6, and by an increased Desmin expression. Additionally, the M1 phenotype transformation of macrophages was evidenced by the increased expression levels of CD86, tumor necrosis factor (TNF)‑α and inducible nitric oxide synthase (iNOS), and by the decreased expression levels of CD206, Sirt6, interleukin (IL)‑4 and IL‑10. In vitro assays of macrophages and podocytes demonstrated that glucose promoted macrophage M1 transformation and podocyte apoptosis in a dose‑dependent manner and attenuated Sirt6 expression. Macrophages transformed into the M2 phenotype following the overexpression of Sirt6 by the successful transfection of macrophages with a Sirt6 overexpression plasmid. Sirt6 was also overexpressed in podocytes. In a Transwell co‑culture system, the overexpression of Sirt6 in macrophages (but not the overexpression of Sirt6 in podocytes) protected the podocytes from high‑glucose‑induced injury. However, the apoptosis of the podocytes overexpressing Sirt6 (induced by transfection with a Sirt6 overexpression plasmid) still increased when these podocytes were co‑cultured with macrophages in high‑glucose medium. These protective effects were evidenced by the inhibition of apoptosis, the upregulation of the expression levels of Bcl‑2 and CD206, as well as by the decreased expression levels of Bax and CD86. On the whole, the findings of this study suggest that Sirt6 protects podocytes against injury in a mimicked diabetic kidney microenvironment by activating M2 macrophages, indicating that Sirt6 can act as an immune response regulatory factor in DN‑associated renal inflammatory injury.

View Figures

View References

1	Gallagher H and Suckling RJ: Diabetic nephropathy: Where are we on the journey from pathophysiology to treatment? Diabetes Obes Metab. 18:641–647. 2016. View Article : Google Scholar : PubMed/NCBI
2	Dronavalli S, Duka I and Bakris GL: The pathogenesis of diabetic nephropathy Nat Clin Pract Endocrinol Metab. 4:444–452. 2008. View Article : Google Scholar
3	Ma R, Liu L, Jiang W, Yu Y and Song H: FK506 ameliorates podocyte injury in type 2 diabetic nephropathy by down-regulating TRPC6 and NFAT expression. Int J Clin Exp Pathol. 8:14063–14074. 2015.
4	Eremina V, Baelde HJ and Quaggin SE: Role of the VEGF–a signaling pathway in the glomerulus: Evidence for crosstalk between components of the glomerular filtration barrier. Nephron, Physiol. 106:32–37. 2007. View Article : Google Scholar
5	Mundel P and Kriz W: Structure and function of podocytes: An update. Anat Embryol (Berl). 192:385–397. 1995. View Article : Google Scholar
6	Mathieson PW: What has the immune system got against the glomerular podocyte? Clin Exp Immunol. 134:1–5. 2003. View Article : Google Scholar : PubMed/NCBI
7	Gordon S and Taylor PR: Monocyte and macrophage heterogeneity Nat Rev Immunol. 5:953–964. 2005.
8	Chow F, Ozols E, Nikolic-Paterson DJ, Atkins RC and Tesch GH: Macrophages in mouse type 2 diabetic nephropathy: Correlation with diabetic state and progressive renal injury. Kidney Int. 65:116–128. 2004. View Article : Google Scholar
9	Nguyen D, Ping F, Mu W, Hill P, Atkins RC and Chadban SJ: Macrophage accumulation in human progressive diabetic nephropathy. Nephrology (Carlton). 11:226–231. 2006. View Article : Google Scholar
10	Tesch GH: Macrophages and diabetic nephropathy. Semin Nephrol. 30:290–301. 2010. View Article : Google Scholar : PubMed/NCBI
11	Minton K: Macrophages: A transcription factor to call their own. Nat Rev Immunol. 11:742011. View Article : Google Scholar : PubMed/NCBI
12	Hofkens W, Storm G, Berg WVD and Lent PV: Inhibition of M1 macrophage activation in favour of M2 differentiation by liposomal targeting of glucocorticoids to the synovial lining during experimental arthritis. Ann Rheum Dis. 70(Suppl 2): pp. 702011, View Article : Google Scholar
13	Gordon S: Alternative activation of macrophages. Nat Rev Immunol. 3:23–35. 2003. View Article : Google Scholar : PubMed/NCBI
14	Gertler AA and Cohen HY: SIRT6, a protein with many faces. Biogerontology. 14:629–639. 2013. View Article : Google Scholar : PubMed/NCBI
15	Tennen RI, Berber E and Chua KF: Functional dissection of SIRT6: Identification of domains that regulate histone deacetylase activity and chromatin localization. Mech Ageing Dev. 131:185–192. 2010. View Article : Google Scholar : PubMed/NCBI
16	Tennen RI, Bua DJ, Wright WE and Chua KF: SIRT6 is required for maintenance of telomere position effect in human cells. Nat Commun. 2:4332011. View Article : Google Scholar : PubMed/NCBI
17	Beauharnois JM, Bolívar BE and Welch JT: Sirtuin 6: A review of biological effects and potential therapeutic properties. Mol Biosyst. 9:1789–1806. 2013. View Article : Google Scholar : PubMed/NCBI
18	Michishita E, McCord RA, Berber E, Kioi M, Padilla-Nash H, Damian M, Cheung P, Kusumoto R, Kawahara TL, Barrett JC, et al: SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin. Nature. 452:492–496. 2008. View Article : Google Scholar : PubMed/NCBI
19	Yuan J, Pu M, Zhang Z and Lou Z: Histone H3-K56 acetylation is important for genomic stability in mammals. Cell Cycle. 8:1747–1753. 2009. View Article : Google Scholar : PubMed/NCBI
20	Mostoslavsky R, Chua KF, Lombard DB, Pang WW, Fischer MR, Gellon L, Liu P, Mostoslavsky G, Franco S, Murphy MM, et al: Genomic instability and aging-like phenotype in the absence of mammalian SIRT6. Cell. 124:315–329. 2006. View Article : Google Scholar : PubMed/NCBI
21	Zhong L, D'Urso A, Toiber D, Sebastian C, Henry RE, Vadysirisack DD, Guimaraes A, Marinelli B, Wikstrom JD, Nir T, et al: The histone deacetylase Sirt6 regulates glucose homeostasis via Hif1alpha. Cell. 140:280–293. 2010. View Article : Google Scholar : PubMed/NCBI
22	Wang X, Liu J, Zhen J, Zhang C, Wan Q, Liu G, Wei X, Zhang Y, Wang Z, Han H, et al: Histone deacetylase 4 selectively contributes to podocyte injury in diabetic nephropathy. Kidney Int. 86:712–725. 2014. View Article : Google Scholar : PubMed/NCBI
23	Sun H, Tian J, Xian W, Xie T and Yang X: Pentraxin-3 attenuates renal damage in diabetic nephropathy by promoting M2 macrophage differentiation. Inflammation. 38:1739–1747. 2015. View Article : Google Scholar : PubMed/NCBI
24	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar
25	Zanotto C, Hansen F, Galland F, Batassini C, Federhen BC, da Silva VF, Leite MC, Nardin P and Gonçalves CA: Glutamatergic alterations in STZ-induced diabetic rats are reversed by Exendin-4. Mol Neurobiol. Aug 25–2018.Epub ahead of print. View Article : Google Scholar : 2018.PubMed/NCBI
26	Nunes KP, de Oliveira AA, Szasz T, Biancardi VC and Webb RC: Blockade of toll-like receptor 4 attenuates erectile dysfunction in diabetic rats. J Sex Med. 15:1235–1245. 2018. View Article : Google Scholar : PubMed/NCBI
27	Huang YC, Wu BH, Chu YL, Chang WC and Wu MC: Effects of tempeh fermentation with Lactobacillus plantarum and Rhizopus oligosporus on streptozotocin-induced type II diabetes mellitus in rats. Nutrients. 10:102018. View Article : Google Scholar
28	Wu M, Yang Y, Wang M, Zeng F, Li Q, Liu W, Guo S, He M, Wang Y, Huang J, et al: Exogenous pancreatic kallikrein improves diabetic cardiomyopathy in streptozotocin-induced diabetes. Front Pharmacol. 9:8552018. View Article : Google Scholar : PubMed/NCBI
29	Inoki K, Mori H, Wang J, Suzuki T, Hong S, Yoshida S, Blattner SM, Ikenoue T, Rüegg MA, Hall MN, et al: mTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in mice. J Clin Invest. 121:2181–2196. 2011. View Article : Google Scholar : PubMed/NCBI
30	Wang W, Wang Y, Long J, Wang J, Haudek SB, Overbeek P, Chang BH, Schumacker PT and Danesh FR: Mitochondrial fission triggered by hyperglycemia is mediated by ROCK1 activation in podocytes and endothelial cells. Cell Metab. 15:186–200. 2012. View Article : Google Scholar : PubMed/NCBI
31	Casalena G, Krick S, Daehn I, Yu L, Ju W, Shi S, Tsai SY, D'Agati V, Lindenmeyer M, Cohen CD, et al: Mpv17 in mitochondria protects podocytes against mitochondrial dysfunction and apoptosis in vivo and in vitro. Am J Physiol Renal Physiol. 306:F1372–F1380. 2014. View Article : Google Scholar : PubMed/NCBI
32	Bechtel W, Helmstädter M, Balica J, Hartleben B, Kiefer B, Hrnjic F, Schell C, Kretz O, Liu S, Geist F, et al: Vps34 deficiency reveals the importance of endocytosis for podocyte homeostasis. J Am Soc Nephrol. 24:727–743. 2013. View Article : Google Scholar : PubMed/NCBI
33	Liu N, Xu L, Shi Y and Zhuang S: Podocyte autophagy: A potential therapeutic target to prevent the progression of diabetic nephropathy. J Diabetes Res. 2017:35602382017. View Article : Google Scholar : PubMed/NCBI
34	Inoue R, Asanuma K, Seki T, Nagase M and Osafune K: New therapeutic insights for chronic kidney disease provided by podocytology. Nihon Yakurigaku Zasshi. 143:27–33. 2014.In Japanese. View Article : Google Scholar : PubMed/NCBI
35	Lennon R, Randles MJ and Humphries MJ: The importance of podocyte adhesion for a healthy glomerulus. Front Endocrinol (Lausanne). 5:1602014. View Article : Google Scholar
36	Kestilä M, Lenkkeri U, Männikkö M, Lamerdin J, McCready 6P, Putaala H, Ruotsalainen V, Morita T, Nissinen M, Herva R, et al: Positionally cloned gene for a novel glomerular protein - nephrin - is mutated in congenital nephrotic syndrome. Mol Cell. 1:575–582. 1998. View Article : Google Scholar
37	Wang Z, Liu J and Sun W: Effects of asiaticoside on levels of podocyte cytoskeletal proteins and renal slit diaphragm proteins in adriamycin-induced rat nephropathy. Life Sci. 93:352–358. 2013. View Article : Google Scholar : PubMed/NCBI
38	Bohle A, Wehrmann M, Bogenschütz O, Batz C, Müller CA and Müller GA: The pathogenesis of chronic renal failure in diabetic nephropathy. Investigation of 488 cases of diabetic glomerulo-sclerosis. Pathol Res Pract. 187:251–259. 1991. View Article : Google Scholar : PubMed/NCBI
39	Furuta T, Saito T, Ootaka T, Soma J, Obara K, Abe K and Yoshinaga K: The role of macrophages in diabetic glomerulo-sclerosis. Am J Kidney Dis. 21:480–485. 1993. View Article : Google Scholar : PubMed/NCBI
40	Yonemoto S, Machiguchi T, Nomura K, Minakata T, Nanno M and Yoshida H: Correlations of tissue macrophages and cytoskeletal protein expression with renal fibrosis in patients with diabetes mellitus. Clin Exp Nephrol. 10:186–192. 2006. View Article : Google Scholar : PubMed/NCBI
41	Guo Y, Song Z, Zhou M, Yang Y, Zhao Y, Liu B and Zhang X: Infiltrating macrophages in diabetic nephropathy promote podocytes apoptosis via TNF-α-ROS-p38MAPK pathway. Oncotarget. 8:53276–53287. 2017.PubMed/NCBI
42	Liu H, Dong H, Jiang L, Li Z and Ma X: Bleomycin inhibits proliferation and induces apoptosis in TPC-1 cells through reversing M2-macrophages polarization. Oncol Lett. 16:3858–3866. 2018.PubMed/NCBI
43	Heusinkveld M, de Vos van Steenwijk PJ, Goedemans R, Ramwadhdoebe TH, Gorter A, Welters MJ, van Hall T and van der Burg SH: M2 macrophages induced by prostaglandin E2 and IL-6 from cervical carcinoma are switched to activated M1 macrophages by CD4⁺ Th1 cells. J Immunol. 187:1157–1165. 2011. View Article : Google Scholar : PubMed/NCBI
44	Assadi-Porter FM, Reiland H, Sabatini M, Lorenzini L, Carnicelli V, Rogowski M, Selen Alpergin ES, Tonelli M, Ghelardoni S, Saba A, et al: Metabolic reprogramming by 3-iodothyronamine (T1AM): A new perspective to reverse obesity through co-regulation of sirtuin 4 and 6 expression. Int J Mol Sci. 19:192018. View Article : Google Scholar
45	Aditya R, Kiran AR, Varma DS, Vemuri R and Gundamaraju R: A review on SIRtuins in diabetes. Curr Pharm Des. 23:2299–2307. 2017. View Article : Google Scholar : PubMed/NCBI
46	Feng J, Lu C, Dai Q, Sheng J and Xu M: SIRT3 facilitates amniotic fluid stem cells to repair diabetic nephropathy through protecting mitochondrial homeostasis by modulation of mitophagy. Cell Physiol Biochem. 46:1508–1524. 2018. View Article : Google Scholar : PubMed/NCBI
47	Huynh FK, Hershberger KA and Hirschey MD: Targeting sirtuins for the treatment of diabetes. Diabetes Manag (Lond). 3:245–257. 2013. View Article : Google Scholar
48	Kitada M, Takeda A, Nagai T, Ito H, Kanasaki K and Koya D: Dietary restriction ameliorates diabetic nephropathy through anti-inflammatory effects and regulation of the autophagy via restoration of Sirt1 in diabetic Wistar fatty (fa/fa) rats: A model of type 2 diabetes. Exp Diabetes Res. 2011:9081852011. View Article : Google Scholar : PubMed/NCBI
49	Li C, Cai F, Yang Y, Zhao X, Wang C, Li J, Jia Y, Tang J and Liu Q: Tetrahydroxystilbene glucoside ameliorates diabetic nephropathy in rats: Involvement of SIRT1 and TGF-β1 pathway. Eur J Pharmacol. 649:382–389. 2010. View Article : Google Scholar : PubMed/NCBI
50	Shang G, Gao P, Zhao Z, Chen Q, Jiang T, Zhang N and Li H: 3,5-Diiodo-l-thyronine ameliorates diabetic nephropathy in streptozotocin-induced diabetic rats. Biochim Biophys Acta. 1832:674–684. 2013. View Article : Google Scholar : PubMed/NCBI
51	Wang X, Meng L, Zhao L, Wang Z, Liu H, Liu G and Guan G: Resveratrol ameliorates hyperglycemia-induced renal tubular oxidative stress damage via modulating the SIRT1/FOXO3a pathway. Diabetes Res Clin Pract. 126:172–181. 2017. View Article : Google Scholar : PubMed/NCBI
52	Caton PW, Richardson SJ, Kieswich J, Bugliani M, Holland ML, Marchetti P, Morgan NG, Yaqoob MM, Holness MJ and Sugden MC: Sirtuin 3 regulates mouse pancreatic beta cell function and is suppressed in pancreatic islets isolated from human type 2 diabetic patients. Diabetologia. 56:1068–1077. 2013. View Article : Google Scholar : PubMed/NCBI
53	Morigi M, Perico L, Rota C, Longaretti L, Conti S, Rottoli D, Novelli R, Remuzzi G and Benigni A: Sirtuin 3-dependent mitochondrial dynamic improvements protect against acute kidney injury. J Clin Invest. 125:715–726. 2015. View Article : Google Scholar : PubMed/NCBI
54	Blasiak J, Arabski M, Krupa R, Wozniak K, Zadrozny M, Kasznicki J, Zurawska M and Drzewoski J: DNA damage and repair in type 2 diabetes mellitus. Mutat Res. 554:297–304. 2004. View Article : Google Scholar : PubMed/NCBI
55	Grindel A, Guggenberger B, Eichberger L, Pöppelmeyer C, Gschaider M, Tosevska A, Mare G, Briskey D, Brath H and Wagner KH: Oxidative stress, DNA damage and DNA repair in female patients with diabetes mellitus type 2. PLoS One. 11:e01620822016. View Article : Google Scholar : PubMed/NCBI
56	Kuang J, Chen L, Tang Q, Zhang J, Li Y and He J: The role of Sirt6 in obesity and diabetes. Front Physiol. 9:1352018. View Article : Google Scholar : PubMed/NCBI
57	Kuang J, Zhang Y, Liu Q, Shen J, Pu S, Cheng S, Chen L, Li H, Wu T, Li R, et al: Fat-specific Sirt6 ablation sensitizes mice to high-fat diet-induced obesity and insulin resistance by inhibiting lipolysis. Diabetes. 66:1159–1171. 2017. View Article : Google Scholar : PubMed/NCBI
58	Xiong X, Zhang C, Zhang Y, Fan R, Qian X and Dong XC: Fabp4-Cre-mediated Sirt6 deletion impairs adipose tissue function and metabolic homeostasis in mice. J Endocrinol. 233:307–314. 2017. View Article : Google Scholar : PubMed/NCBI
59	Xiao C, Wang RH, Lahusen TJ, Park O, Bertola A, Maruyama T, Reynolds D, Chen Q, Xu X, Young HA, et al: Progression of chronic liver inflammation and fibrosis driven by activation of c-JUN signaling in Sirt6 mutant mice. J Biol Chem. 287:41903–41913. 2012. View Article : Google Scholar : PubMed/NCBI
60	Tarantino G, Finelli C, Scopacasa F, Pasanisi F, Contaldo F, Capone D and Savastano S: Circulating levels of sirtuin 4, a potential marker of oxidative metabolism, related to coronary artery disease in obese patients suffering from NAFLD, with normal or slightly increased liver enzymes. Oxid Med Cell Longev. 2014:9206762014. View Article : Google Scholar : PubMed/NCBI
61	Huynh FK, Hu X, Lin Z, Johnson JD and Hirschey MD: Loss of sirtuin 4 leads to elevated glucose- and leucine-stimulated insulin levels and accelerated age-induced insulin resistance in multiple murine genetic backgrounds. J Inherit Metab Dis. 41:59–72. 2018. View Article : Google Scholar :
62	Zhang XL, Guo YF, Song ZX and Zhou M: Vitamin D prevents podocyte injury via regulation of macrophage M1/M2 phenotype in diabetic nephropathy rats. Endocrinology. 155:4939–4950. 2014. View Article : Google Scholar : PubMed/NCBI